2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cutaneous T Cell Lymphoma
Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin lymphoma, primarily affecting the skin. It arises from malignant T-cells, a type of white blood cell, leading to the formation of skin lesions. Research in CTCL focuses on understanding its pathogenesis, developing targeted therapies, and improving patient outcomes. Recent advancements include the identification of genetic mutations driving CTCL progression and the development of novel immunotherapies and targeted drugs such as monoclonal antibodies and immune checkpoint inhibitors. Additionally, studies exploring the tumor microenvironment and the role of immune cells in CTCL aim to uncover new treatment strategies. Collaborative efforts between researchers and clinicians continue to drive progress in unraveling the complexities of CTCL and devising more effective therapies for patients.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China